- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.12. | Eisai unit hands over $46M for Japanese rights to Newron's schizophrenia add-on | ||
| 13.12. | Chutes & Ladders-AI firm Xaira powers up C-suite with pharma vet | ||
| 13.12. | Boundless Bio drops clinical-stage cancer drug over phase 1 data, shakes up C-suite | ||
| 13.12. | Gilead's O'Day relishes Berger reunion as cancer specialist agrees to join from Sanofi | ||
| 13.12. | Editas lays off 65% of staff, including CMO, after fruitless search for reni-cel partner | ||
| 12.12. | iTeos deprioritizes cancer candidate despite 'encouraging' phase 2 data | ||
| 12.12. | FDA expands use of J&J's Impella heart pumps to pediatric patients | ||
| 12.12. | Evotec, Novo Nordisk's drug discovery accelerator debuts first 3 projects, adds 5 partners | ||
| 12.12. | PeptiDream's macrocyclic peptides preserve muscle mass in mice given semaglutide | ||
| 12.12. | Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line | ||
| 12.12. | Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal | ||
| 12.12. | Corcept's cortisol modulator fails to slow ALS decline, linked to 'gastrointestinal upset' at onset | ||
| 12.12. | Multiomics startup Pleno raises $25M for commercial launch, plucks new CEO from Illumina | ||
| 12.12. | Keros' stock tanks after halting 2 arms of hypertension trial over fluid buildups around heart | ||
| 12.12. | Industry M&A volume declined 8% this year compared to '23: PwC | ||
| 11.12. | Bavarian Nordic plans to shut down San Diego R&D site, lay off 48 employees | ||
| 11.12. | Reverse, reverse: Liver disease biotech Hepion and Pharma Two B call off merger | ||
| 11.12. | USPSTF endorses HPV self-collection tests for cervical cancer screening | ||
| 11.12. | AnaptysBio scraps atopic dermatitis asset after antibody fails to meet all endpoints in ph. 2 | ||
| 11.12. | Jury convicts ex-CytoDyn CEO on 9 counts tied to biotech fraud | ||
| 11.12. | Candel burns bright as phase 3 prostate cancer win sends stock up 200% | ||
| 11.12. | Angitia raises $120M series C to fund trio of musculoskeletal trials | ||
| 11.12. | Capstan Medical collects $110M for robotic heart valve replacements | ||
| 11.12. | Q32's stock plunges in wake of phase 2 eczema fail for anti-IL-7R antibody | ||
| 11.12. | 2 Boston-area biotechs shed staff, fuse to form genetic medicines company nChroma Bio |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
